DoW Arthritis Translational Research Award
Can you apply?
This grant is for researchers studying arthritis translational pathways. Eligible applicants typically include academic institutions, nonprofit research organizations, and small businesses with established research capabilities. Applicants must have institutional infrastructure to conduct clinical or preclinical arthritis research. Geographic scope is typically U.S.-based organizations. Funded activities support early-stage translational research advancing arthritis treatments from lab toward patient application.
This program emphasizes research that bridges basic science and clinical application. Investigators must demonstrate institutional commitment through letters of support. The application process is competitive and requires detailed scientific justification.
Program description
Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research that will accelerate critical findings into clinically relevant solutions. Research funded under this award mechanism will be hypothesis-driven, high-impact applied research that is relevant to Service Members, Veterans, their Families and the American public. Research addressing any and all types of arthritis is encouraged.
Distinctive Features: The FY26 ATRP TRA mechanism is intended to support preclinical or animal research and may not be used for clinical research or clinical trials. Basic research, as defined in Section 3.1.2, is not allowed. A key aspect of this award mechanism is impact. The application should explicitly state how outcomes of the proposed research will significantly advance arthritis research, particularly in accelerating critical findings into clinically relevant solutions.
Preliminary and/or published data, originating from research conducted by the applicant(s) or others, is required.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Federal Application for Federal Assistance)
- Project Narrative (typically 15-25 pages)
- Budget and Budget Justification (detailed for each year)
- Biosketches of key personnel (NIH format)
- Letters of Institutional Support
- Research Plan with Specific Aims
- Timeline and Milestones
Program contact
- 👤 JoAnn Martin Grantor
- 📧 help@eBRAP.org
- 📞 301-619-2594
Funding track record
Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$2,265,729,366
-
$800,631,761
-
$74,531,880
-
$67,205,571
-
$53,718,832
-
$34,191,124
-
$24,907,742
-
$21,394,379
-
$19,100,256
-
$19,002,641
Top States by Funding
- MD 10 awards $3,150.1M
- NC 11 awards $132.3M
- FL 8 awards $99.8M
- CA 11 awards $99.3M
- MA 7 awards $75.2M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.
| 2024 | $1,483,968,520 | |
| 2025 | $1,201,153,417 |
FAQ
Who is eligible to apply for this grant?
Universities, research institutions, nonprofits, and small businesses are typically eligible. Your institution must have appropriate research infrastructure and compliance capacity.
What is the application deadline?
The deadline is October 22, 2026. Applications open May 1, 2026. Plan to submit well before the final deadline.
What types of arthritis research does this fund?
This program typically funds translational research moving from bench to clinical application. Basic mechanistic studies paired with pathway to clinical relevance are competitive.
How competitive is this award?
DOD research programs are highly competitive. Success rates are typically 10-20%. Strong preliminary data and clear translational pathway significantly strengthen applications.
What is the typical funding level?
Award amounts vary but translational research awards typically range from $150K to $500K+ annually. Check the current funding opportunity announcement for specific limits.
💡 Tips for applicants
- Emphasize the translational pathway clearly. Show explicit steps from your research toward clinical arthritis treatment applications.
- Build strong preliminary data section. DOD reviewers expect published or strong unpublished evidence supporting your approach.
- Secure institutional letters early. Your research office and department leadership must demonstrate commitment to the project timeline and resources.
- Address military relevance if applicable. If your research connects to service member health, make this explicit in the proposal narrative.
- Use the agency's review criteria language. Mirror terminology from the funding announcement in your proposal to improve reviewer alignment.
⚠️ Common mistakes
Weak translational pathway. Many applications lack clear, testable steps connecting basic science to clinical outcome. Applications without preliminary published or strong unpublished data rarely succeed. DOD reviewers expect significant institutional infrastructure and commitment documentation.
Similar grants
- OPEN FY26 Bureau of Land Management Rangeland Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Cultural and Paleontological Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Youth Conservation Corps – Bureau wide — Bureau of Land Management
- OPEN Infertility Training Center — Office of the Assistant Secretary for Health
- OPEN FY26 Bureau of Land Management Eastern Nevada Conservation, Recreation and Development – NEVADA BLM — Bureau of Land Management